Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Non-cash Items (2021 - 2025)

Organogenesis Holdings has reported Non-cash Items over the past 5 years, most recently at $20.0 million for Q4 2025.

  • Quarterly results put Non-cash Items at $20.0 million for Q4 2025, up 692.26% from a year ago — trailing twelve months through Dec 2025 was $20.0 million (up 692.26% YoY), and the annual figure for FY2025 was $20.0 million, up 692.26%.
  • Non-cash Items for Q4 2025 was $20.0 million at Organogenesis Holdings, up from $10.8 million in the prior quarter.
  • Over the last five years, Non-cash Items for ORGO hit a ceiling of $38.5 million in Q4 2021 and a floor of $1.5 million in Q1 2023.
  • Median Non-cash Items over the past 5 years was $5.4 million (2023), compared with a mean of $8.1 million.
  • Biggest five-year swings in Non-cash Items: plummeted 94.17% in 2022 and later surged 692.26% in 2025.
  • Organogenesis Holdings' Non-cash Items stood at $38.5 million in 2021, then plummeted by 94.17% to $2.2 million in 2022, then surged by 357.33% to $10.3 million in 2023, then crashed by 75.45% to $2.5 million in 2024, then surged by 692.26% to $20.0 million in 2025.
  • The last three reported values for Non-cash Items were $20.0 million (Q4 2025), $10.8 million (Q3 2025), and $5.5 million (Q2 2025) per Business Quant data.